Search Results - "Vásová, I"

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma by MAYER, J, KORISTEK, Z, VASOVA, I, VORLICEK, J, VODVARKA, P

“…We treated 40 patients with poor prognosis lymphomas. Patients with non-Hodgkin's lymphoma (NHL, n = 14) received MINE chemotherapy (mesna, ifosfamide 1330…”
Get full text

Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected by Stefancikova, L, Moulis, M, Fabian, P, Falkova, I, Vasova, I, Kren, L, Macak, J, Smardova, J

“…The cytogenetic and diagnostic hallmark of mantle cell lymphoma (MCL) is translocation t(11;14)(q13;q32), resulting in overexpression of cyclin D1. Cyclin D1…”
Get more information

Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute by Petera, J, Macharová, H, Pohanková, R, Malír, A, Coupek, P, Konecný, M, Patera, J, Pecina, J, Drbal, J, Koukalová, H, Vásová, I

“…Radiotherapy and chemotherapy, alone or in combination, are curative treatment methods in early stages of Hodgkin's disease (HD). The choice of treatment…”
Get full text

New approaches to management of multiple myeloma by Hájek, R, Vásová, I, Adam, Z, Mayer, J

“…A new era of multiple myeloma (MM) management includes new approaches such as genetic marking and gene therapy, immunotherapy, stimulation of graft versus…”
Get more information

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up by Müller, Fabian, Taubmann, Jule, Bucci, Laura, Wilhelm, Artur, Bergmann, Christina, Völkl, Simon, Aigner, Michael, Rothe, Tobias, Minopoulou, Ioanna, Tur, Carlo, Knitza, Johannes, Kharboutli, Soraya, Kretschmann, Sascha, Vasova, Ingrid, Spoerl, Silvia, Reimann, Hannah, Munoz, Luis, Gerlach, Roman G., Schäfer, Simon, Grieshaber-Bouyer, Ricardo, Korganow, Anne-Sophie, Farge-Bancel, Dominique, Mougiakakos, Dimitrios, Bozec, Aline, Winkler, Thomas, Krönke, Gerhard, Mackensen, Andreas, Schett, Georg

“…In this case series of 15 patients with severe autoimmune disease, selective deep depletion of B lymphocytes with CD19 CAR T-cell therapy was effective in…”
Get full text

Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies by Kubesová, H, Penka, M, Král, Z, Adam, Z, Vásová, I, Tomíska, M, Vorlícek, J

“…Mucositis is a common complication following chemotherapy. Clinical findings similar to herpetic infection are observed in some patients. Acyclovir…”
Get more information

Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation by Hájek, R, Adam, Z, Vásová, I, Král, Z

“…Melphalan has brought the first improvement in the therapy of multiple myeloma at the beginning of the sixties. The median of survival was prolonged from…”
Get more information

Evaluation of Acute and Early Cardiotoxicity in Survivors of Hodgkin's Disease Treated with ABVD or BEACOPP Regimens by Elbl, L., Vasova, I., Kral, Z., Tomaskova, I., Smardova, L., Wagnerova, B., Jedlicka, F., Vorlicek, J.

“…The study was conducted to compare the presence of cardiotoxicity after the treatment of Hodgkin's disease with the standard ABVD or BEACOPP protocol. We…”
Get full text

Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma by Elbl, L, Vasova, I, Tomaskova, I, Jedlicka, F, Navratil, M, Pospisil, Z, Vorlicek, J

“…Authors conducted a one-year prospective study to determine whether CHOP regimen (cyclophosphamide, doxorubicin, vincristin, and prednisone), used in the…”
Get more information

Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen by Elbl, L, Vasova, I, Kral, Z, Navratil, M, Smardova, L, Vorlicek, J

“…The prospective study was conducted to determine whether standard regimen ABVD used in the treatment of Hodgkin's disease is accompanied by the presence of…”
Get more information

Chronic fatigue syndrome in cancer patients. Diagnostic and treatment options by Jedlicka, F, Elbl, L, Vásová, I, Tomásková, I, Vorlícek, J, Spinar, J

“…Fatigue is the most frequent symptom accompanying a cancer disease and its treatment according to the visual analogue scale. Fatigue is reported by as many as…”
Get more information

Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group by Sýkorová, A, Belada, D, Smolej, L, Pytlík, R, Benesová, K, Vásová, I, Papajík, T, Sálek, D, Procházka, V, Matuska, M, Brejcha, M, Kubácková, K, Kabícková, E, Móciková, H, Campr, V, Trnený, M

“…The Ann Arbor system is typically used for the staging of Non-Hodgkin's lymphomas. This classification was nevertheless originally developed in the 1970s for…”
Get more information

Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy by Elbl, L, Vásová, I, Navrátil, M, Vorlícek, J, Malásková, L, Spinar, J

“…The aim of the study was to find out the relationship between plasmatic levels of brain natriuretic peptide (BNP) and echocardiographic indicators of left…”
Get more information

Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy by Elbl, L, Vásová, I, Navrátil, M, Tomásková, I, Jedlicka, F, Chaloupka, V, Vorlícek, J

“…Chronic cardiotoxicity of doxorubicin occurs at least one year after the chemotherapy is finished. As such, it is a serious late complication in patients with…”
Get more information

Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients by Janíková-Oborilová, A, Mayer, J, Dvorákova, D, Mejstrík, P, Navritíl, M, Vásová, I, Kren, L, Matuska, M

“…Evaluation of practical value of monitoring t(14:18) in peripheral blood in follicular lymphoma. t(14;18) was tested in 115 follicular lymphoma patients by…”
Get more information

Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy by Elbl, L, Vásová, I, Krejcí, M, Navrátil, M, Tomásková, I, Jedlicka, F, Chaloupka, V, Mayer, J, Vorlícek, J

“…The authors examined whether high-dose chemotherapy with hematogenic tissue transplantation might negatively affect function of left ventricle (LV) in oncology…”
Get more information

Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma by STEF ANCIKOVA, Lenka, MOULIS, Mojmir, FABIAN, Pavel, RAVCUKOVA, Barbora, VASOVA, Ingrid, MUZIK, Jan, MALCIKOVA, Jitka, FALKOVA, Iva, SLOVACKOVA, Jana, SMARDOVA, Jana

“…Mantle cell lymphoma (MCL) is typified by translocation t(11;14)(q13;q32) causing upregulation of cyclin D1 and deregulation of cell cycle. The cyclin D1…”
Get full text

Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products by Vásová, I, Mayer, J

“…The use of leukodepleted cellular blood components may reduce some adverse effect of transfusion in certain indications. This review presents the adverse…”
Get more information

Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma by Mayer, J, Vásová, I, Korístek, Z, Navrátil, M, Klabusay, M, Doubek, M, Vorlícek, J, Cernilová, I, Vodvárka, P, Petráková, K

“…Treatment of early relapsing or resistant non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) remains problematic. High-dose chemotherapy followed by…”
Get more information

Evaluation of the clinical effectivity and toxicity of the FDN regimen (fludarabin, mitoxantron, dexamethason) in patients with follicular lymphoma by Oborilová, A, Mayer, J, Korístek, Z, Hofmanová, Z, Vásová, I, Navrátil, M, Vinklárková, J, Muzikárová, M, Klabusay, M, Matuska, M

“…One of the perspective therapeutic possibilities in follicular lymphomas (FL) is the fludarabine-based regimen FND (fludarabine, mitoxantron, dexamethason)…”
Get more information